VP-16-213 and cyclophosphamide in small cell lung cancer: a long-term followup report.
作者信息
Britell J C, Eagan R T, Lee R E
出版信息
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2130-1.
PMID:230899
Abstract
摘要
相似文献
1
VP-16-213 and cyclophosphamide in small cell lung cancer: a long-term followup report.依托泊苷（VP - 16 - 213）与环磷酰胺治疗小细胞肺癌：长期随访报告
Cancer Treat Rep. 1979 Nov-Dec;63(11-12):2130-1.
2
[Treatment of anaplastic carcinoma of the lung with VP 16-213].
Med Clin (Barc). 1982;79(7):322-4.
3
Cyclophosphamide and VP-16-213 with or without cisplatin in squamous cell and small cell lung cancers.环磷酰胺和依托泊苷联合或不联合顺铂用于治疗鳞状细胞癌和小细胞肺癌。
Cancer Treat Rep. 1981 May-Jun;65(5-6):453-8.
4
Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.
Cancer Treat Rep. 1977 May-Jun;61(3):489-90.
5
The role of VP-16 in the treatment of small-cell lung cancer: studies of the West of Scotland Lung Cancer Group.依托泊苷（VP - 16）在小细胞肺癌治疗中的作用：苏格兰西部肺癌研究组的研究
Semin Oncol. 1985 Mar;12(1 Suppl 2):2-6.
6
[Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
Med Clin (Barc). 1984 May 19;82(19):836-9.
7
High-dose etoposide (VP-16) in small-cell lung cancer.
Semin Oncol. 1985 Mar;12(1 Suppl 2):42-4.
8
9
[Effects of oral etoposide in small cell carcinoma of the lung].
Gan To Kagaku Ryoho. 1984 Jun;11(6):1244-7.
Zotero 插件